It is essential for cells to control precisely which of the many genes of their genetic material they use. This is done in so-called transcription factories, molecular clusters in the nucleus. Researchers have now found that the formation of transcription factories resembles the condensation of liquids.

Following recent clinical trial, biotech firm Enbiosis announces a breakthrough in the treatment of irritable bowel syndrome, which affects one in every ten people.

An extensive body of research into Human African trypanosomiasis (HAT), also known as sleeping sickness, has revealed new insights into the deadly parasitic disease that threatens the lives of millions of people in 36 sub-Saharan African countries.

A team of EPFL researchers has developed tiny 10-gram robots that can communicate with each other, assign roles among themselves and complete complex tasks together. These reconfigurable robots are simple in structure, but they can jump and crawl to explore uneven surfaces.

Following the trend towards biopharmaceutical medicine Sartorius launched for its ambr 250 modular benchtop automated mini bioreactor system new vessels, which are designed for gentle stirring and optimum growth of cell lines. The system allows cost-effective, scalable process development of cell and gene therapies.

For the first time, researchers have solved the structure of viral anti-Crispr proteins attached to a bacterial Crispr surveillance complex, revealing precisely how viruses incapacitate the bacterial defense system.

By mimicking photosynthesis, the light-driven process that plants use to produce sugars, MIT researchers have designed a new type of photocatalyst that can absorb light and use it to drive a variety of chemical reactions.

Global biotech company Orgenesis announced a collaboration agreement with Tel Aviv Sourasky Medical Center to advance Point-of-Care development and commercialization of cell and gene and therapies.

Using computer simulations, an international research team shows that the synthesis of heavy elements is typical for certain black holes with orbiting matter accumulations, so-called accretion disks. The predicted abundance of the formed elements provides insight into which heavy elements need to be studied in future laboratories — such as the Facility for Antiproton and Ion Research (Fair), which is currently under construction — to unravel the origin of heavy elements.

Pharmaceutical company Boehringer Ingelheim opened a new tablet production facility in Ingelheim. Starting immediately, the Solids Launch Factory will manufacture all the company’s new drugs introduced in tablet form (solids). Digital tools are a crucial pillar of the new plant.